Volume 11, Issue 2 (2025)
IEM 2025, 11(2): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghelighi-Ghojogh M, Saberi A H, Amirkhanlou S. Investigating the Effect of Hemoperfusion Therapy on Laboratory and Clinical Factors in COVID-19 Patients: A Cross-Sectional Study. IEM 2025; 11 (2)
URL: http://iem.modares.ac.ir/article-4-78706-en.html
URL: http://iem.modares.ac.ir/article-4-78706-en.html
1- Neonatal and Children’s Research Center, Department of Biostatistics and Epidemiology, School of Health, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran
2- Medical Doctor, Golestan University of Medical Sciences, Gorgan, Iran
3- Department of Internal Medicine, Clinical Research Development Unit (CRDU), Shahid Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran ,amirkhanlousaeid@gmail.com
2- Medical Doctor, Golestan University of Medical Sciences, Gorgan, Iran
3- Department of Internal Medicine, Clinical Research Development Unit (CRDU), Shahid Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran ,
Abstract: (89 Views)
Background: With the epidemic of the emerging COVID-19 disease in the world in 2019 and the lack of a definitive and effective treatment for it, medical science practically faced a new challenge, this study aimed to investigation the effect of hemoperfusion therapy on laboratory and clinical factors in COVID-19 patients.
Materials & Methods: In this cross-sectional study, 49 patients with severe COVID-19, who had indications for hemoperfusion were examined in 2020-2021. The patients underwent four hemoperfusion sessions after inserting a vascular catheter and preparing a special filter. Changes in laboratory and clinical factors before and after each hemoperfusion session were carefully recorded, and the data were analyzed using SPSS software.
Findings: The results of the study showed that the average age of the patients was 55.5 ± 13.9 years. Changes in the patients’ blood oxygen saturation levels after each hemoperfusion session showed a statistically significant improvement trend, the average values before and after the first session were 86.7±7.2% and 88.5±5.7%, respectively, indicating a significant increase (p= .009). Also, the inflammatory factor CRP (C-reactive protein) and blood platelet levels were significantly reduced after each hemoperfusion session.
Conclusion: This study showed that hemoperfusion could improve patients’ blood oxygen saturation values without causing any special complications and could also have a clear effect on clearing inflammatory factors and CRP from the blood.
Materials & Methods: In this cross-sectional study, 49 patients with severe COVID-19, who had indications for hemoperfusion were examined in 2020-2021. The patients underwent four hemoperfusion sessions after inserting a vascular catheter and preparing a special filter. Changes in laboratory and clinical factors before and after each hemoperfusion session were carefully recorded, and the data were analyzed using SPSS software.
Findings: The results of the study showed that the average age of the patients was 55.5 ± 13.9 years. Changes in the patients’ blood oxygen saturation levels after each hemoperfusion session showed a statistically significant improvement trend, the average values before and after the first session were 86.7±7.2% and 88.5±5.7%, respectively, indicating a significant increase (p= .009). Also, the inflammatory factor CRP (C-reactive protein) and blood platelet levels were significantly reduced after each hemoperfusion session.
Conclusion: This study showed that hemoperfusion could improve patients’ blood oxygen saturation values without causing any special complications and could also have a clear effect on clearing inflammatory factors and CRP from the blood.
Article Type: Original Research |
Subject:
Virology
Received: 2024/12/29 | Accepted: 2025/04/4 | Published: 2025/04/21
Received: 2024/12/29 | Accepted: 2025/04/4 | Published: 2025/04/21
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |